Physician profile
John Chinnick Root
NPI 1871589341
$571.28
in general payments reported to CMS, 2019-2025
14 companies · $44.71 in 2025
The $44.71 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $32.55 · 2021: $96.45 · 2022: $233 · 2023: $13.03 · 2025: $44.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $89.31 | 2019-2022 | |
| Lilly USA, LLC | $80.22 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $69.64 | 2019-2022 | |
| Pfizer INC. | $56.34 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.25 | 2020-2022 | |
| Amgen INC. | $48.88 | 2022 | |
| Abbvie INC. | $44.43 | 2022 | |
| Glaxosmithkline, LLC. | $35.97 | 2019-2021 | |
| Exact Sciences Corporation | $21.58 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $20.27 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.16 | 2022 | |
| Dexcom, INC. | $13.03 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $11.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.